2028, Communication and Vaccines - Pharmacy Technician Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2028

Communication

Vaccines

4mn dose shortage of GSK’s childhood rotavirus vaccine expected

European Pharmaceutical Review

AUGUST 15, 2022

According to Reuters , Kenya, Tanzania, Senegal and Cameroon have either run out of or are close to running out of vaccines to protect children against the deadly rotavirus infection following undisclosed “manufacturing challenges” at GSK. We are witnessing the largest sustained drop in childhood immunisation in a generation.

Vaccines

Vaccines Communication

Can your LNP manufacturing platform cope with the pace of the mRNA revolution?

Pharmaceutical Technology

APRIL 27, 2023

The successful development and deployment of the mRNA-based COVID-19 vaccines has catalysed the biopharma industry and paved the way to expand this drug modality to new therapeutic areas. billion by 2028. Excluding vaccines, there are five mRNA therapeutic products in clinical trial development as of November 2022.

Vaccines

Vaccines Documentation Communication

4mn dose shortage of GSK’s childhood rotavirus vaccine expected

Can your LNP manufacturing platform cope with the pace of the mRNA revolution?

Stay Connected